New shot aims to shield seniors from dangerous RSV virus
NCT ID NCT07128121
Summary
This study is testing a new mRNA vaccine designed to protect older adults from Respiratory Syncytial Virus (RSV), a common cause of serious lung infections. It will enroll 500 healthy participants aged 60 and older to check the vaccine's safety and how well it triggers an immune response. The study will also look at giving a booster shot one or two years after the first vaccination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hunan Provincial Center for Disease Control and Prevention
Changsha, Hunan, China
Conditions
Explore the condition pages connected to this study.